MolNFT v2 · #116558 · protein
Development of a therapeutic monoclonal antibody targeting secreted aP2 to treat type 2 diabetes.
MolNFT v2 record #116558 on GenesisL1: PDB 5D8J, “Development of a therapeutic monoclonal antibody targeting secreted aP2 to treat type 2 diabetes.”. Protein, 221 residues. 3D structure, sequence proof, BLAST and structure search…
- PDB
- 5D8J
- Type
- protein
- Length
- 221 residues
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.